Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 16, 2010

View Archived Issues

Italian researchers discover new SMO receptor antagonists for cancer

Austrian scientists describe new GABA(A) receptor ligands

Daiichi Sankyo claims new ligands of voltage-dependent calcium channel subunit alpha2-delta

Pfizer discloses new PDE9A inhibitors

Praecis Pharma identifies novel ADAMTS-4 inhibitors

MK-4827 receives E.U. orphan drug status in ovarian cancer

Emergent BioSolutions acquires Trubion Pharmaceuticals

Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis

Tenofovir vaginal gel reduces risk of HIV infection in women

Iontophoretically delivered terbinafine enters phase II trial in onychomycosis

Sipuleucel-T prolongs survival in phase III trial in castration-resistant prostate cancer

FT-23 attenuates diastolic dysfunction in model of diabetic cardiomyopathy

Allozyne partners with Sigma-Aldrich for cycloaddition chemistry

TLV and Emergent BioSolutions to codevelop H5 influenza vaccine

AVEO completes enrollment in phase III tivozanib trial in renal cell carcinoma

Dexamethasone intravitreal implant receives E.U. orphan drug status for noninfectious uveitis

Epitomics spins out new antibody therapeutics company, Apexigen

Humanetics receives licenses for medical radiation countermeasures

Novavax reports preclinical data on respiratory syncytial virus vaccine RSV-F

Stem Cell Therapeutics to begin phase IIa trial of hCG and EPO in traumatic brain injury

Syndax raises funds for ENCORE-301 trial in breast cancer

NIH begins phase I trial of its dengue vaccine Tetravax-DV

CeNeRx secures funds for phase II trial of new CX-157 formulation for depression

EMA validates CTI's expanded pediatric program for pixantrone in NHL

FDA grants orphan drug status to BC-819 in pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...